Six-month oral regimens for drug-resistant TB found cost-effective: ICMR study
Published on: Feb. 13, 2026, 7:44 a.m. | Source: Hindustan Times
Shorter all-oral regimens can improve treatment adherence, reduce patient morbidity, and enable faster return to normal life, while also lowering the burden on the health system
